General Information of the m6A Target Gene (ID: M6ATAR01641)
Target Name Tripartite motif-containing protein 72 (TRIM72)
Synonyms
EC 2.3.2.27; Mitsugumin-53; Mg53
    Click to Show/Hide
Gene Name TRIM72
Chromosomal Location 16p11.2
Family TRIM/RBCC family
Function
Muscle-specific protein that plays a central role in cell membrane repair by nucleating the assembly of the repair machinery at injury sites. Specifically binds phosphatidylserine. Acts as a sensor of oxidation: upon membrane damage, entry of extracellular oxidative environment results in disulfide bond formation and homooligomerization at the injury site. This oligomerization acts as a nucleation site for recruitment of TRIM72-containing vesicles to the injury site, leading to membrane patch formation. Probably acts upstream of the Ca(2+)-dependent membrane resealing process. Required for transport of DYSF to sites of cell injury during repair patch formation. Regulates membrane budding and exocytosis. May be involved in the regulation of the mobility of KCNB1-containing endocytic vesicles (By similarity).
    Click to Show/Hide
Gene ID 493829
Uniprot ID
TRI72_HUMAN
HGNC ID
HGNC:32671
KEGG ID
hsa:493829
Full List of Crosstalk(s) between m6A Modification and Epigenetic Regulation Related to This Regulator
Histone modification
m6A Regulator: RNA-binding motif protein 15 (RBM15)
In total 1 item(s) under this m6A regulator
Crosstalk ID: M6ACROT03216
Epigenetic Regulator Histone-lysine N-methyltransferase 2A (KMT2A)
Regulated Target Histone H3 lysine 4 trimethylation (H3K4me3)
Crosstalk relationship Histone modification → m6A
Disease Preeclampsia
Drug Actinomycin D
m6A Regulator: YTH domain-containing family protein 2 (YTHDF2)
In total 1 item(s) under this m6A regulator
Crosstalk ID: M6ACROT03217
Epigenetic Regulator Histone-lysine N-methyltransferase 2A (KMT2A)
Regulated Target Histone H3 lysine 4 trimethylation (H3K4me3)
Crosstalk relationship Histone modification → m6A
Disease Preeclampsia
Drug Actinomycin D
References
Ref 1 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800023753)